VistaGen Therapeutics | 4:持股变动声明-董事 Rotunno Mary L.
VistaGen Therapeutics | 4:持股变动声明-董事 GIN JERRY B
VistaGen Therapeutics | 4:持股变动声明-董事 FitzPatrick Margaret M
VistaGen Therapeutics | 4:持股变动声明-董事 Curley Joanne
VistaGen Therapeutics | 4:持股变动声明-董事 Cunningham Ann Michelle
VistaGen Therapeutics | 4:持股变动声明-董事 SAXE JON S
VistaGen Therapeutics | SC 13G/A:超过5%持股股东披露文件(修正)-Kenneth Griffin(5.8%),Citadel Advisors LLC(5.6%)等
VistaGen Therapeutics | SC 13G:超过5%持股股东披露文件-Nantahala Capital Management, LLC(9.9%),Wilmot B. Harkey(9.9%)等
VistaGen Therapeutics | SC 13G/A:超过5%持股股东披露文件(修正)-Great Point Partners, LLC(9.99%),Dr. Jeffrey R. Jay, M.D.(9.99%)等
VistaGen Therapeutics | SC 13G/A:超过5%持股股东披露文件(修正)-Point72 Asset Management, L.P.(3.0%),Point72 Capital Advisors, Inc.(3.0%)等
VistaGen Therapeutics | SC 13G:超过5%持股股东披露文件-The Vanguard Group(6.79%)
VistaGen Therapeutics | 4:持股变动声明-高管 Adler Reid G.
VistaGen Therapeutics | 4:持股变动声明-高管 Singh Shawn
VistaGen Therapeutics | 3:首次持股声明-首席运营官 Prince Joshua S.
VistaGen Therapeutics | SC 13G:超过5%持股股东披露文件-Chen Yu(9.9%),TCG Crossover GP II, LLC(7.5%)等
VistaGen Therapeutics | SC 13G:超过5%持股股东披露文件-BVF Partners L.P.(9.99%),BVF Inc.(9.99%)等
VistaGen Therapeutics | SC 13G:超过5%持股股东披露文件-Kenneth Griffin(5.7%),Citadel Advisors LLC(5.6%)等
VistaGen Therapeutics | SC 13G:超过5%持股股东披露文件-Great Point Partners, LLC(9.99%),Dr. Jeffrey R. Jay, M.D.(9.99%)等
VistaGen Therapeutics | 4:持股变动声明-股东 COMMODORE CAPITAL LP
VistaGen Therapeutics | SC 13G/A:超过5%持股股东披露文件(修正)-Commodore Capital LP(9.9%),Commodore Capital Master LP(9.9%)
暂无数据